AMPH
Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. annual/quarterly total liabilities history from 2013 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Amphastar Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 840.5M, a 0.55% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. total liabilities for 2025 were 840.5M, a 0.55% decrease from 2024.
- Amphastar Pharmaceuticals Inc. total liabilities for 2024 were 845.2M, a 3.24% decrease from 2023.
- Amphastar Pharmaceuticals Inc. total liabilities for 2023 were 873.5M, a 309.46% increase from 2022.
- Amphastar Pharmaceuticals Inc. total liabilities for 2022 were 213.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Amphastar Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $840 |
| 2024 | $845 |
| 2023 | $873 |
| 2022 | $213 |
| 2021 | $226 |
| 2020 | $183 |
| 2019 | $159 |
| 2018 | $149 |
| 2017 | $117 |
| 2016 | $98 |
| 2015 | $95 |
| 2014 | $108 |
| 2013 | $87 |
| Amphastar Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $840 |
| 2024-12-31 | $845 |
| 2023-12-31 | $873 |
| 2022-12-31 | $213 |
| 2021-12-31 | $226 |
| 2020-12-31 | $183 |
| 2019-12-31 | $159 |
| 2018-12-31 | $149 |
| 2017-12-31 | $117 |
| 2016-12-31 | $98 |
| 2015-12-31 | $95 |
| 2014-12-31 | $108 |
| 2013-12-31 | $87 |
Amphastar Pharmaceuticals Inc. Total Liabilities — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMPH's total liabilities history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.